Treatable meningeal involvement in Waldenström's macroglobulinemia.
D000368:Aged; D002330:Carmustine / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D007145:Immunoglobulin kappa-Chains / Q000032:analysis; D008214:Lymphocytes / Q000473:pathology; D008578:Meninges / Q000473:pathology*; D010950:Plasma Cells / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy / Q000473:pathology*
D007075:Immunoglobulin M; D007145:Immunoglobulin kappa-Chains; D002330:Carmustine; D011241:Prednisone